HealthStream (HSTM) Stock: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$30.36
0.65 (2.19%)
▲
5d:
+5.16%
30d:
+2.33%
90d:
+6.86%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 02, 2026
30d
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HSTM trades at premium valuation expecting 6.3% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: HSTM trades at premium valuation expecting 6.3% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.76
Based on 12.6% avg growth
INTRINSIC VALUE TODAY
$24.69
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $30.36, which is considered extended relative to its 30-day fair value range of $28.81 to $29.64. From a valuation perspective, the stock is trading at a premium (Forward PE: 34.3) compared to its historical average (28.5). At these levels, the market is pricing in 6.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSTM is in a strong uptrend. The price is approaching resistance at $30.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.50 (+13.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HSTM is in a strong uptrend. The price is approaching resistance at $30.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.50 (+13.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.81 -
$29.64
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($34.50)
- NEUTRAL: Trading at premium valuation - market expects 6.3% growth which is achievable
- NEUTRAL: Bottoming setup forming (48/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$28.81 -
$29.64
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$28.55
Resistance Level
$30.53
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
34.31
Wall Street Target
$34.50
(+13.6%)
Revenue Growth (YoY)
12.5%
Earnings Growth (YoY)
28.4%
Profit Margin
6.6%
Valuation Premium vs History
+6.3% premium
PE vs Historical
34.3 vs 28.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.3%
(market-implied from PE analysis)
1-Year Target
$32.27
(+6%)
2-Year Target
$34.31
(+13%)
3-Year Target
$36.47
(+20%)
3-Yr Target (if PE normalizes)
(PE: 34→29)
PE COMPRESSION
$30.30
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 34.3, Growth: 21.2%)
$54.10
(+78%)
Base:
(SPY PE: 20.4, Growth: 21.2%)
$32.17
(+6%)
Bear:
(PE: 17.3, Growth: 21.2%)
$27.34
(-10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (34x PE) as earnings recover.
Trailing PE: 41.26 | Current EPS (TTM): $0.72
Bull Case
$40.17
(+32%)
Analyst growth 22.9%, PE expands to 45.4
Base Case
$36.52
(+20%)
Market implied 22.9%, PE stable at 41.3
Bear Case
$20.20
(-34%)
Severe decline -20.0%, PE contracts to 35.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 01, 2026 7:04 PM ET
Data refreshes hourly during market hours. Next update: 8:04 PM
Data refreshes hourly during market hours. Next update: 8:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 60 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 80 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 41 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 51 HOLD |
